Abstract
Background
With cardiovascular diseases standing as a leading cause of mortality worldwide, the interplay between diet-induced inflammation, as quantified by the Dietary Inflammatory Index (DII), and heart failure biomarker NT-proBNP has not been investigated in the general population.
Methods
This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004, encompassing 10,766 individuals. The relationship between the DII and NT-proBNP levels was evaluated through multivariable-adjusted regression models. To pinpoint crucial dietary components influencing NT-proBNP levels, the LASSO regression model was utilized. Stratified analyses were then conducted to examine the associations within specific subgroups to identify differential effects of the DII on NT-proBNP levels across diverse populations.
Results
In individuals without heart failure, a unit increase in the DII was significantly associated with an increase in NT-proBNP levels. Specifically, NT-proBNP levels rose by 9.69 pg/mL (95% CI: 6.47, 12.91; p < 0.001) without adjustments, 8.57 pg/mL (95% CI: 4.97, 12.17; p < 0.001) after adjusting for demographic factors, and 5.54 pg/mL (95% CI: 1.75, 9.32; p = 0.001) with further adjustments for health variables. In participants with a history of heart failure, those in the second and third DII quartile showed a trend towards higher NT-proBNP levels compared to those in the lowest quartile, with increases of 717.06 pg/mL (95% CI: 76.49–1357.63, p = 0.030) and 855.49 pg/mL (95% CI: 156.57–1554.41, p = 0.018). Significant interactions were observed in subgroup analyses by age (<50: β = 3.63, p = 0.141; 50–75: β = 18.4, p<0.001; >75: β = 56.09, p<0.001), gender (men: β = 17.82, p<0.001; women: β = 7.43, p = 0.061),hypertension (β = 25.73, p<0.001) and diabetes (β = 38.94, p<0.001).
Conclusion
This study identified a positive correlation between the DII and NT-proBNP levels, suggesting a robust link between pro-inflammatory diets and increased heart failure biomarkers, with implications for dietary modifications in cardiovascular risk management.
Funder
Yan'an Science and Technology Bureau
Publisher
Public Library of Science (PLoS)
Reference62 articles.
1. Global Burden of Cardiovascular Diseases and Risks, 1990–2022;GA Mensah;J Am Coll Cardiol,2023
2. The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond;GA Mensah;J Am Coll Cardiol,2019
3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart;TA McDonagh;Fail.,2022
4. Reappraising the role of inflammation in heart failure;L Adamo;Nat Rev Cardiol,2020
5. Neutrophils as regulators of cardiovascular inflammation;C Silvestre-Roig;Nat Rev Cardiol,2020